Renal Cancer
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors.
October 23, 2024
Prognosis and progression of phagocytic regulatory factor-related gene combinations in clear cell renal cell carcinoma (ccRCC).
October 22, 2024
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.
October 21, 2024
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration.
October 21, 2024
Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study.
October 18, 2024
Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings.
October 17, 2024
Dense Collagen I as a Biomimetic Material to Track Matrix Remodelling in Renal Carcinomas.
October 16, 2024
Ultra-processed food consumption and renal cell carcinoma incidence and mortality: results from a large prospective cohort.
October 15, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the novel NAMPT Inhibitor OT-82.
October 15, 2024
The Influence of Pre-ablation Embolization Particle Size on the Size of the Microwave Ablation Zone in a Porcine Orthotopic Renal Tumor Model.
October 14, 2024
Predicting post-surgical complications using renal scoring systems.
October 14, 2024
Real-world effectiveness of first- and second-line anti-angiogenesis therapy in RCC: analysis of a UK-based population.
October 11, 2024
Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma.
October 11, 2024